Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorYavuz, Serap Şimşek
dc.contributor.authorAkar, Ahmet Rüçhan
dc.contributor.authorAydoğdu, Sinan
dc.contributor.authorDeniz, Denef Berzeg
dc.contributor.authorDemir, Hakan
dc.contributor.authorHazırolan, Tuncay
dc.contributor.authorHızmalı, Lokman
dc.date.accessioned2022-10-11T07:42:41Z
dc.date.available2022-10-11T07:42:41Z
dc.date.issued2020en_US
dc.identifier.citationYavuz, S., Akar, A., Aydogdu, S., Deniz, D., Demir, H., Hazırolan, T., ... & Yilmaz-Karadag, F. (2020). Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 48(2).en_US
dc.identifier.issn10165169
dc.identifier.urihttps://doi.org/10.5543/tkda.2020.89689
dc.identifier.urihttps://hdl.handle.net/20.500.12513/4633
dc.description.abstractInfective endocarditis (IE) is a rare but still important as an infectious disease due to high rate of morbidity and substantial mortality. Although IE is not a notifiable disease in Turkey, and an incidence study has not been performed, the incidence may be higher than that in the developed countries due to frequent predisposing cardiac conditions and higher rates of nosocomial bacteremia, which may lead to IE in risk groups. IE generally affects the elderly in developed countries but it is frequently encountered among young individuals in Turkey. In order to reduce mortality and morbidity, it is critical to diagnose IE, to determine the causative agent, and to start treatment rapidly. Most patients cannot be diagnosed at the first visit, about half can be diagnosed after 3 months, and the disease often goes unnoticed. In patients diagnosed with IE, the rate of the identification of a causative organism is significantly lower in Turkey than that in developed countries. Some important microbiological diagnostic tests are not performed in most centers and several antimicrobials that are recommended as the first option for the treatment particularly antistaphylococcal penicillins, are unavailable in Turkey. These problems necessitate reviewing the epidemiological, laboratory, and clinical characteristics of IE in our country, as well as the current information about its diagnosis, treatment, and prevention together with local data. The diagnosis and treatment processes of IE should be standardized at every stage so that the management can be conducted in a setting in which physicians of various specialties are involved and is consistent with the current recommendations. The Study Group for Infective Endocarditis and Other Cardiovascular Infections of the Turkish Society of Clinical Microbiology and Infectious Diseases called for the collaboration of the relevant specialist organizations to establish a consensus report on the diagnosis, treatment, and prevention of IE in the context of current information and local data in Turkey. © 2020 Turkish Society of Cardiology.en_US
dc.language.isoengen_US
dc.publisherTurkish Society of Cardiologyen_US
dc.relation.isversionof10.5543/tkda.2020.89689en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectConsensus reporten_US
dc.subjectInfective endocarditisen_US
dc.titleDiagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019 [İnfektif endokarditin tanısı, tedavisi ve önlenmesi: Ulusal uzlaşı raporu-2019]en_US
dc.typeotheren_US
dc.relation.journalTurk Kardiyoloji Dernegi Arsivien_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorIDLokman Hızmalı / 0000-0001-9548-3030en_US
dc.identifier.volume48en_US
dc.identifier.issue2en_US
dc.identifier.startpage187en_US
dc.identifier.endpage226en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster